Key words: activated Ras oncogene, replication stress, senescence-associated heterochromatin foci, hydroxyurea, etoposide, bacterial toxin, histone 3 trimethylated on lysine 9, DNA damage response Abbreviations: BrdU, 5-bromo-2'-deoxyuridine; DAPI, 4',6-diamidino-2-phenylindole; DDR, DNA damage response; DOXO, doxorubicin; ET, etoposide; H3K9Me3, histone H3 (tri)methylated at lysine 9; HdCDT, Haemophilus ducreyi cytolethal distending toxin; HIRA, histone repressor A; HP1, heterochromatin protein 1; HU, hydroxyurea; pRb, retinoblastoma protein; PML, promyelocytic leukemia protein; SA-β-gal, senescence-associated beta-galactosidase; SAHF, senescence-associated heterochromatin foci changes and secretion of a spectrum of cytokines, proteases and growth factors, collectively referred to as the 'senescenceassociated secretory phenotype'. 7-12 Additional functional markers of senescence reflect the underlying mechanistic basis of the senescent state, in particular constitutive DNA damage signaling. [13] [14] [15] [16] Importantly, none of the listed individual features or 'markers' of cellular senescence is sufficiently specific or unique to unequivocally identify senescent cells on its own, and therefore a set of such markers, when expressed concomitantly, is currently applied to define senescence. This set of senescence features is generally regarded as being shared by cells undergoing replicative ©2 0 1 1 L a n d e s B i o s c i e n c e .
Introduction
Cellular senescence is a state of stable cell cycle arrest accompanied by a set of characteristic morphological and physiological features that distinguish senescent cells not only from proliferating cells, but also from arrested quiescent or terminally differentiated cells.
1,2 Such senescence-associated features typically include irreversible proliferation arrest, enlarged cellular morphology, expression of senescence-associated β-galactosidase activity (SA-β-gal), 3 enhanced nuclear heterochromatinization 4 and increased numbers of nuclear PML bodies, 5, 6 as well as transcriptional Cellular senescence, an irreversible proliferation arrest evoked by stresses such as oncogene activation, telomere dysfunction or diverse genotoxic insults, has been implicated in tumor suppression and aging. primary human fibroblasts undergoing oncogene-induced or replicative senescence are known to form senescence-associated heterochromatin foci (SAHF), nuclear DNA domains stained densely by DApI and enriched for histone modifications including lysine9-trimethylated histone H3. While cellular senescence occurs also in premalignant human lesions, it is unclear how universal SAHF formation is among various cell types, under diverse stresses and whether SAHF occur in vivo. Here, we report that human primary fibroblasts (BJ and MRC-5) and primary keratinocytes undergoing replicative senescence or premature senescence induced by oncogenic H-Ras, diverse chemotherapeutics and bacterial cytolethal distending toxin, show differential capacity to form SAHF. Whereas all tested cell types formed SAHF in response to activated H-Ras, only MRC-5, but not BJ fibroblasts or keratinocytes, formed SAHF under senescence induced by etoposide, doxorubicin, hydroxyurea, bacterial intoxication or telomere attrition. In addition, DApI-defined SAHF were detected on paraffin sections of Ras-transformed cultured fibroblasts, but not human lesions at various stages of tumorigenesis. overall, our results indicate that unlike the widely present DNA damage response marker γH2AX, SAHF is not a common feature of cellular senescence. Whereas SAHF formation is shared by diverse cultured cell types under oncogenic stress, SAHF are cell-type-restricted under genotoxin-induced and replicative senescence. Furthermore, while the DNA/DApI-defined SAHF formation in cultured cells parallels enhanced expression of p16 ink4a , such 'prototypic' SAHF are not observed in tissues, including premalignant lesions, irrespective of enhanced p16 ink4a and other features of cellular senescence.
Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type-and insult-dependent manner, and follow expression of p16 ink4a senescence caused by various stimuli, and whether or not SAHF are applicable to studies in vivo. In this study, we have addressed some of these important open questions about SAHF biology. Specifically, we have examined whether SAHF form in multiple human cell types including primary fibroblasts and epithelial cells, and under conditions that lead to replicative senescence or premature senescence induced by activated Ras oncogene, 22 bacterial intoxication 42 and several genotoxic chemotherapeutics, respectively, all insults known to trigger cellular senescence. Furthermore, we took advantage of available tissues from characterized cohorts of premalignant and malignant human lesions, known to display (or lack) features of cellular senescence, including enhanced accumulation of heterochromatin markers HP1 and H3K9Me3 as well as γH2AX. The results of these analyses, as well as detection of γH2AX and levels of p16 ink4a in the diverse experimental settings, are presented below. Overall, our findings reveal unexpected selectivity of SAHF formation with respect to cellular context, challenge the possibility that SAHF might serve as a universal marker of senescence and raise questions about the nature and biological significance of such selectivity.
Results

SAHF formation is common in oncogene-induced senescence.
As Ras-induced senescence was the initial scenario employed in the pioneering studies of Narita and Lowe to propose the SAHF concept, 4 we first assessed whether SAHF formation is shared by multiple types of human cells undergoing oncogene-induced senescence. To this end, we utilized a well established model of the oncogenic mutant H-Ras V12 , 22 expressed in two types of human diploid primary fibroblasts (strains BJ and MRC-5) and primary human keratinocytes, respectively. In time course experiments, lentiviral transduction of H-Ras V12 led in all three cell types to widespread cellular senescence by day 12 after transduction, as judged by changes in morphology, enhanced SA-β-Gal staining ( Fig. 1) and grossly diminished DNA replication indicated by inhibited incorporation of BrdU (Sup. Table 1 ). The formation of SAHF was monitored by DAPI DNA staining combined with immunofluorescence detection of the heterochromatin marker H3K9Me3 and HP1γ ( Fig. 1 and data not shown) , features typically associated with SAHF. 4 The first detectable SAHF appeared at day 5 in all three cell types, with the highest percentage of the initially positive cells seen in MRC-5 ( Fig. 2A) . The initial differences in relative proportions of SAHF-positive cells among the three cell types became minimized by day 12, however, when no statistically significant differences in percentages of SAHFpositive cells were found ( Fig. 2A) . Of note, the proportions of SAHF-positive cells did not change during extended periods of cultivation until 250 days after oncogene transduction. Also, both the partial colocalization of DAPI-stained heterochromatin foci with H3K9Me3 ( Fig. 1) , and the observed percentages of SAHF-containing cells were consistent with results of a previous study analyzing Ras-induced senescence in IMR-90 cells, another strain of human diploid fibroblasts. 4 Altogether, our data extend previous studies and indicate that the ability to form SAHF during oncogene-induced senescence senescence, due to telomere shortening towards the end of the cell's life span, [17] [18] [19] and the so-called premature senescence, due to more acute stressors such as oxidative stress and other DNA damaging insults 20, 21 and activated oncogenes. 22 The efforts to identify markers, 23 and better understand the molecular basis of senescence, are mainly motivated by the important roles played by cellular senescence in both normal physiology and diverse pathologies. Such established and emerging biological roles of cellular senescence encompass suppression of tumorigenesis, [24] [25] [26] involvement in degenerative diseases and organismal aging, 2, 27, 28 responses to various medical treatments, 29 and contribution to tissue repair processes. 30 Mechanistically, the onset and maintenance of the senescent state involve action of two major tumor suppressive pathways, p53-p21 and p16 ink4a -pRb. 31, 32 Upstream signals that trigger these pathways commonly include, but may not be exclusively restricted to, persistent activity of the DNA damage response (DDR) machinery, 14, 15 orchestrated by the major signaling modules of ATM-Chk2 and ATR-Chk1 kinases. 33 A functional biomarker that is used most often to detect activated DDR is a histone variant H2AX phosphorylated by ATM/ATR on serine 139, commonly known as γH2AX. 34 This nuclear marker is widely detected in cells undergoing diverse modes of senescence, [13] [14] [15] [16] 35 either as a predominantly focal pattern of γH2AX (reflecting mainly DNA double strand breaks and/or dysfunctional telomeres signaled primarily by activated ATM) or a more even global nuclear pattern of γH2AX (phosphorylated mainly by ATR in response to oxidative or replication stresses, for example). Another mechanistically important aspect of cellular senescence is the formation of chromatin structures called senescence-associated heterochromatin foci (SAHF). 36 These domains of facultative heterochromatin can be detected cytologically as compacted foci of DNA stained by DAPI. Whereas DAPI staining of nuclei of normal human cells is relatively uniform, senescent cells show up to 30-50 punctate DAPI-stained DNA foci. 4 The SAHF are formed by nuclease resistant compaction of chromatin, 4 and each focus apparently represents condensed chromatin of one chromosome. 37 SAHF also feature protein modifications typical of transcriptionally silent heterochromatin, such as lysine 9-trimethylated histone H3 (H3K9Me3). 4 A number of additional proteins are known to contribute to formation and/or maintenance of the SAHF, including histone chaperones HIRA and Asf1, 38 heterochromatin proteins 1 (HP1), 4 and high-mobility group A (HMGA) proteins, 39 histone variant macroH2A, 40 and pRb. 4 The p16 ink4a -pRB pathway appears to be required for SAHF formation, 4, 38 and functionally SAHF have been implicated in transcriptional silencing of proliferationpromoting genes. 4 Thus, the under-phosphorylated, active pRb initiates chromatin silencing at E2F target genes exemplified by cyclin A, 4 which might then provide nucleation sites for large scale HIRA/ASF1a-mediated heterochromatinization. 41 Despite the accumulating wealth of information about the formation and composition of SAHF, however, these structures have largely been studied only in a very few strains of cultured fibroblasts, and there is a striking paucity of data on their relevance for a broader spectrum of cell types, occurrence in ©2 0 1 1 L a n d e s B i o s c i e n c e .
D o n o t d i s t r i b u t e .
drug exposure (data not shown). Among the three chemotherapeutics used, HU and ET were more potent inducers of SAHF in MRC-5 cells than DOXO, despite the fact that DOXO evoked robust cell cycle arrest and DNA damage, as monitored by BrDU incorporation and γH2AX, respectively (Sup. Fig. 1 ). We conclude that unlike the universal occurrence of SAHF in oncogene-induced senescence, SAHF formation is restricted to only one of the three normal human cell types undergoing senescence evoked by several genotoxic drugs.
Restricted SAHF formation in replicative and bacterial toxin-induced senescence. To extend our study to other presently known forms of cellular senescence, we next examined SAHF formation during the most recently described senescence mode induced by bacterial intoxication, 42 and the traditionally most studied replicative senescence. First, we exposed MRC-5, BJ and keratinocytes to cytolethal distending toxin (HdCDT) prepared from Haemophilus ducreyi, 47 a scenario that we recently reported to induce cellular senescence in the subpopulations of various human cell types, both normal and cancer-derived, that upon transformation with activated Ras is shared by various cell types, here represented by human fibroblast strains MRC-5 and BJ and primary keratinocytes.
SAHF formation in drug-induced premature senescence is cell type restricted. Several chemotherapeutic drugs including etoposide, 43 hydroxyurea 44 and doxorubicin 45, 46 are known to induce premature senescence in human cells. To examine whether SAHF formation is a feature associated with drug-induced senescence, exponentially growing MRC-5, BJ and keratinocyte cultures were continually exposed to commonly used doses of hydroxyurea (HU; 600 μM), etoposide (ET; 10 μM) and doxorubicin (DOXO; 100 ng/ml), respectively, and the cells analyzed at days 2, 5, 8 and 12. Each of the agents induced robust senescence phenotypes by day 12 of drug exposure, in all three cell types (see Sup. Fig. 1 for SA-β-Gal staining and Sup. Table 1 for BrdU incorporation). The formation of SAHF was followed by DAPI staining and indirect immunofluorescence as described above for the Ras-induced senescence. In contrast to consistent heterochromatinization and SAHF formation during the Ras oncogene-induced senescence in all three cell types, drug-induced senescence was accompanied by SAHF formation only in MRC-5 cells, but not in BJ or keratinocytes treated with any of the three drugs ( Figs. 2 and 3 ). This differential SAHF formation was not altered even when the experiments were prolonged until day 21 of Table 1 and data not shown).
survive the acute phase of bacterial intoxication. 42 Formation of DAPI-defined SAHF that colocalized with heterochromatin markers H3K9Me3 and HP1γ was observed in HdCDT-exposed senescent MRC-5 cells but not in similarly treated BJ cells and 
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SAHF was not accompanied by analogous lack of heterochromatinization, as the variable nuclear expression patterns of H3K9Me3 and HP1γ markers were partly focal and the proteins expressed at higher levels among both adenomas and carcinomas as compared to normal mucosa ( Fig. 5B and data not shown; reviewed in ref. 48) . The apparent discrepancy between adenoma-associated senescence in vivo and the lack of classical DAPI-defined SAHF was further corroborated by analysis of 14 cases of human colorectal adenoma available as frozen tissue. Using frozen tissues allowed us not only to avoid the potential caveat of paraffin blocks, but also to assess senescence by the SA-β-gal assay directly on sections, an approach that is not feasible on archival paraffin sections. Consistent with the data obtained on paraffin sections, no clear evidence of the classical DNA/DAPI-defined SAFH was seen upon examination of these adenoma frozen sections, despite the positive variable and partly even focal, expression pattern of the heterochromatin markers HP1γ, H3K9Me3 and SA-β-gal activity (data not shown and Sup. Material reviewed in ref. 48 ). Thus, while our data on immunofluorescence patterns of the H3K9Me3 and HP1γ markers in human tissues are consistent with previous reports on generally enhanced heterochromatinization in tumors, the observed heterochromatin domains appear to be distinct from the classical DNA/DAPI-defined SAHF observed in cell culture models undergoing senescence.
SAHF formation correlates with p16 ink4a accumulation and with the lack of proliferation. Taken together, the experimental data obtained with cultured senescent cells and the somewhat unexpected results from the analyses of the human tissue specimens raised some conceptually important questions that we decided to address by additional experiments.
First, considering the apparent overall lack of the classical SAHF formation in human tumors in vivo (this study), yet their shared occurrence in all examined cell types undergoing Ras-mediated, oncogene-induced senescence in vitro (this study and reviewed in ref. 4 ) and the proposed role of SAHF in silencing proliferation-associated genes such as cyclin A, 4 we asked whether classical SAHF structures might occur in human cultured proliferating cancer cell lines, known to harbor activated Ras and/or other potent oncogenes. As the cancer cell lines grow in vitro, where SAHF are induced by oncogenes and accompany senescence, SAHF formation/persistence in proliferating tumor cells might indicate some tumor-associated bypass of the SAHF-heterochromatinization barrier initially activated as part of the senescence program. To address this issue, we examined a panel of human carcinoma-derived cell lines, including T24, UMSCC-2, HN-5, HCT116, as well as the pre-malignant Hacat cells for SAHF formation. While T24 is a prototypic cancer cell line derived from a tumor harboring activated H-Ras oncogene, HCT116 is a colon cancer cell line matching our clinical colon carcinoma series, and the remaining three cell lines are derived from squamous carcinomas/keratinocytes to match our normal epithelial type examined above. As documented by the examples of fluorescence images (Sup. Fig. 2 ) and the summary of the data (Sup. Table 2), the individual cell lines showed pronounced differences in levels of H3K9Me3 and HP1γ, but no evidence of the DNA/DAPI-positive SAHF. These results support the Next, we compared the early-passage 'young' MRC-5 and BJ fibroblasts with their respective 'old' counterparts undergoing replicative senescence, for potential evidence of SAHF formation. As expected, neither fibroblast strain showed SAHF or senescence features at early passage (Fig. 4B, Sup. Fig. 1 and Sup. Table 1) . Interestingly, the 'old,' senescent populations of MRC-5 cells displayed DAPI-stained DNA/SAHF foci accompanying other features of senescence in contrast to lack of SAHF formation in senescent BJ fibroblasts (Fig. 4B and D) despite the fact that both strains shared other recognized features of the senescent phenotype and the fact that the BJ cells reached the senescent state after more passages in vitro compared to MRC-5. To further validate the apparent differential ability to form SAHF under conditions of replicative senescence between MRC-5 and BJ fibroblasts, the latter cells were observed for additional 150 days after reaching their replicative senescence, still with no evidence of SAHF formation (data not shown).
Collectively, these experiments further support the notion that the ability to form SAHF does not necessarily correlate with the senescent state, here documented for replicative and toxinevoked senescence, and that the MRC-5 cells are more prone to SAHF formation compared to other normal cell types including epithelial cells.
'Classical' DNA/DAPI-defined SAHF are not detected in human tissues and tumors. We have previously reported that cellular senescence observed in clinical specimens of premalignant human lesions is accompanied by enhanced heterochromatinization markers H3K9Me3 and HP1γ that correlated with active DNA damage signaling. 48 On the other hand, to our knowledge the issue of whether these features of senescence are also accompanied by the appearance of the classical DNA/DAPI-defined SAHF in such human specimens has not been investigated so far. To address this important issue, we first asked whether the classical SAHF can be detected on paraffin sections prepared from formalin fixed human fibroblasts undergoing oncogene-induced senescence upon lentiviral transduction of H-Ras V12 in vitro, pelleted and processed into tissue blocks in a manner mimicking the procedures routinely used in clinical pathology. As can be seen from the examples of Ras-transformed BJ fibroblasts, immunohistochemical examination of paraffin sections still revealed the DNA/DAPI-defined SAHF in such specimens (Fig. 5A) , albeit at somewhat lower frequency compared to senescent BJ cells grown and analyzed directly on coverslips (Fig. 1) . These results indicate that routine tissue processing might reduce, but not completely compromise the ability to detect SAHF on paraffin sections. Next, we used the same immunofluorescence detection technique to investigate a series of sections from formalin-fixed paraffin-embedded tissues of human urinary bladder tumors (n = 19), normal human bladder (n = 5) and colon (n = 16), and a cohort of the previously characterized colorectal adenomas (grade III, n = 38) and colon carcinomas (n = 44), for SAHF formation by DAPI staining and expression of H3K9Me3. In contrast to sections from paraffin embedded Ras-transformed BJ cells, no SAHF formation was observed on tissue sections of normal epithelial tissues, adenomas or carcinomas (Fig. 5B  and data not shown) . The apparent lack of DNA/ DAPI-defined ©2 0 1 1 L a n d e s B i o s c i e n c e .
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conclusion based on the analysis of tumor sections (see above and reviewed in ref. 48) , that the presence of elevated heterochromatin markers such as H3K9Me3 and HP1γ (even when forming distinct nuclear foci, see Sup. Fig. 2 ) is compatible with cancer cell proliferation. Furthermore, the data also show that unlike senescent, arrested cells, the proliferating cancer cells do not form the classical DNA/DAPIdefined SAHF, which are apparently distinct from the H3K9Me3/HP1γ-rich heterochromatin domains that do not necessarily reflect silencing of proliferation genes such as cyclin A, a protein highly expressed in all cell lines of our panel (data not shown).
The second, and arguably even more important question, is what molecular mechanistic features might dictate whether or not the classical DAPI/heterochromatin SAHF will form in distinct cell types under otherwise similar conditions and undergoing cellular senescence triggered by various stimuli. Given the distinct propensity to form SAHF among our three models of normal human cells, even under senescence conditions that share the features of inhibited proliferation, morphological changes, SA-β-gal activity and constitutive DNA damage signaling, we argued that the observed differences might reflect variable levels of the p16 ink4a CDK inhibitor, and hence the activation of the pRb pathway, whose role in SAHF formation has been documented. 4, 38 Indeed, biochemical examination of p16 ink4a protein abundance in the two fibroblast strains, MRC-5 and BJ undergoing senescence induced by each of the six stimuli used in our present study, showed a perfect correlation between the observed SAHF formation and the enhanced level of p16 ink4a (Fig. 6) . Specifically, in cell extracts of senescent BJ cells, robust induction of p16 ink4a was only apparent under Ras-induced senescence, the only condition associated with the occurrence of classical DNA/DAPI-defined SAHF in these cells. This contrasted with virtually undetectable levels of 
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tumorigenesis and response to chemotherapy. The key issues raised by our present findings are the pronounced variation of SAHF formation in a cell type-and senescence stimulus-dependent manner, an outstanding link of SAHF formation with oncogene-induced senescence, the fact that SAHF formation seems dispensable for multiple forms of cellular senescence, the close correlation of SAHF formation with enhanced expression of p16 ink4a , the limitations of SAHF as a potential marker of senescence in vivo, as well as the implications of our findings for the concept of heterochromatinization during cancer development and its relevance for therapy. Below, we discuss some of these conceptually important issues in the light of current mechanistic understanding of cellular senescence, including SAHF formation and their emerging significance for biomedicine.
First, our data strongly indicate that SAHF formation is not a universal component of the senescence program and, in fact, appears to be dispensable for multiple modes of cellular senescence, in various cell types. On one hand, we confirm and extend the findings 4,38-40 that some strains of human fibroblasts, here represented by MRC-5 cells, form SAHF during oncogene-induced as well as replicative senescence. More importantly, we show that under senescence induced by most stimuli, including several chemotherapeutic drugs, bacterial intoxication and replicative senescence, SAHF are absent in two of the three cell types used here, the BJ fibroblasts and normal keratinocytes. The latter cells are a mixed population of keratinocytes pooled from several donors, thereby excluding that any rare individual genetic variation or clonal selection events might account for the observed lack of 'classical' SAHF. While it is understandable that most studies on heterochromatinization to date focused on the mechanistic aspects of SAHF formation, such as the involvement of the pRb pathway, histone chaperones, chromatin modifications and remodeling and the impact of SAHF on transcriptional control of cell cycle-promoting genes, 4, [37] [38] [39] [40] 49 these analyses mainly dealt with oncogene-induced senescence and are not sufficiently representative of cellular senescence in its multiple forms. We believe it is equally important to consider a wider spectrum of cellular models and place more emphasis on studies of epithelial cells, represented here by normal human keratinocytes. So far the cellular model predominantly used in the senescence field has been fibroblasts. While useful as a model, the biased focus on fibroblasts is not proportional to their significance in major human pathologies such as cancer, which targets most frequently epithelial cells. Apart from the conceptual significance of the grossly variable SAHF response among diverse p16 ink4a in BJ cells senescent in response to hydroxyurea, etoposide, doxorubicin, bacterial intoxication or replicative exhaustion (Fig. 6B) . In contrast to BJ cells, and consistent with the degree of SAHF formation, extracts of MRC-5 cells undergoing senescence showed increased p16 ink4a in all six scenarios, albeit to different levels. Notably, the highest and lowest abundance of p16 ink4a were found in MRC-5 senescent after Ras and doxorubicin exposure, respectively (Fig. 6A) . These results, as well as the intermediate levels found in the other four senescent scenarios, corresponded well with the relative proportions of cells featuring DNA/DAPI-defined SAHF among the total senescent cell population. These results are consistent with the proposed causal role of the p16 ink4a -pRb pathway in SAHF formation, and their significance is further discussed below.
Discussion
The major contribution of our present study of heterochromatin formation during cellular senescence is the systematic comparative analysis of various types of normal human cells exposed to multiple senescence-inducing stimuli, complemented by analysis of human tissues and tumors. As discussed below, we believe that our study provides new data relevant for several senescence-related aspects of human biology and pathology such as aging, barrier to 
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that also underlie the role of the p16 ink4a -pRb pathway in tumor suppression. 64, 65 Last but not least, our data are relevant to the biological role of senescence as an intrinsic barrier against tumor progression.
66-69
In mechanistic terms, not only the upstream DDR signaling and the p53 pathway 2, 4, 51, 54, 55 but also the p16 ink4a -pRb pathway and heterochromatinization have been implicated in such anti-tumor barrier function. 26 In the light of our present results of enhanced H3K9Me3-positive heterochromatinization, yet without the 'classical' SAHF defined by DAPI-positive foci in human tumors, we speculate that there are at least two intriguing scenarios to consider for SAHF in tumorigenesis. First, enhanced heterochromatinization in vivo may help to block proliferation-driving genes such as the pRb/E2F target genes that become transcriptionally inhibited by SAHF during oncogene-induced senescence. 4, 26 This would imply that the heterochromatin changes detected in vivo are functionally analogous to the 'classical' DAPI-positive SAHF, and contribute to the overall senescence-mediated decrease of cell proliferation, consistent with a tumor suppressive function of the H3K9Me3/HP1γ-rich heterochromatinization seen in human premalignant lesions (reviewed in ref. 48 and this study). If this were the case, then the question is how could advanced, invasive tumors in vivo and cancer cell lines proliferate despite expressing this type of heterochromatin, as is documented for both the clinical specimens as well as the cancer cell lines (reviewed in refs. 48, 70, 71 and this study). This apparent discrepancy might be reconciled if, during cancer progression, the downstream inhibitory impact of heterochromatin on proliferation-promoting genes was somehow bypassed or eliminated, similarly to p53 or Chk2 mutations undermine the DDR-imposed checkpoints originally activated in early lesions. 33, 67, 72 The net result (consistent with our observations on clinical material) would be persistent enhanced heterochromatinization also in invasive tumors, again analogous to persistent ATM/ATR activation and γH2AX positivity often seen in advanced tumors, despite the downstream checkpoint effectors have been blunted. 54 The other potential scenario, however, could reflect the recent studies on the inhibition of DDR by heterochromatin. 73, 74 In this scenario, the altered yet enhanced heterochromatinization, perhaps in the configuration that lacks the DNA/DAPI foci, might help to limit the overall DDR signaling from the ongoing oncogene-induced replication stress and DNA damage 33, 67, 72 and thereby promote cancer survival by bypassing the DDR barrier. This scenario would explain the enhanced degree of heterochromatin reported for invasive human tumors 48, 70 and the rapidly proliferating cancer cell lines (this study). The tumor-suppressive, pro-senescence role and the latter DDR-inhibitory, pro-survival role of enhanced heterochromatinization may not be mutually exclusive. These two heterochromatin states may target distinct sets of genes and differ from each other mechanistically in ways that we still do not understand. Furthermore, the diverse heterochromatin states may also be manifested differentially during different phases of tumor progression, in a context-dependent manner, with the pro-survival mode of heterochromatin being predominant in advanced lesions to limit the impact of DNA damage signaling and ensuing senescence or cell death pathways. cell types, a more 'translational' implication of our present work is that SAFH may not represent a reliable common marker to identify cells undergoing senescence. This notion is further supported by our analyses of human tissues, suggesting that identification of senescent cells in situ through the DAPI-defined SAFH is not feasible.
Further to the potentially usable general markers of senescence, the mechanism that appears to be shared by all major types of senescence is the constitutive DNA damage signaling, often documented by the positivity of γH2AX.
13-16,48,50-52 While analysis of DDR was not a major focus of our present study, we did find elevated γH2AX in all three cell types, and under senescence induced by all six stimuli studied here, an observation that further supports the common involvement of DDR signaling and checkpoints in cellular senescence. Notably, we and others have documented that γH2AX and other functional markers of activated DDR can conveniently be assessed on tissue sections. 13, 48, [53] [54] [55] Although active DDR signaling per se obviously does not uniquely identify senescent cells, we believe that an appropriate combination of γH2AX with some additional cytochemically or histochemically detectable senescence feature(s) may provide a robust tool for assessment of senescence in vivo in the near future.
Another important aspect of our study is the close correlation of the ability to form SAHF and the increased level of p16 ink4a , a CDK inhibitor whose involvement in cellular senescence and also SAHF formation has been widely studied. 4, 22, 32, 40, [56] [57] [58] [59] [60] Our present findings are consistent with the proposed causal role of p16 ink4a in SAHF formation, 4 and with the fact that ectopic overexpression of p16 ink4a can induce SAHF formation in certain cellular context. 4 Also, based on immunohistochemical analysis of human tissues, high expression of p16 ink4a has been proposed to serve as a marker to identify senescent cells in the skin of old individuals. 61 On the other hand, it is evident that elevated p16 ink4a per se may be dispensable for induction of senescence, as documented by only partial correlation of heterochromatinization and p16 ink4a levels in human premalignant lesions, 48 and here for example for the BJ fibroblasts senescent in response to various chemotherapeutics or bacterial intoxication. In fact, low levels of p16 ink4a were reported for BJ cells undergoing replicative senescence. 32 It appears that in cells with low expression of p16 ink4a , senescence induction relies more on the p53-p21 axis, and possibly other mechanisms, likely including also DNA damage checkpoints, only some of which require p53. At the same time, the p16 ink4a -mediated senescence-associated proliferation arrest appears to be more robust and irreversible even upon depletion of p53, as compared to the possibly partially reversible arrest under p16 ink4a -low conditions, at least in replicative senescence. 32 One striking observation, emerging from earlier studies and corroborated by our present findings, is the robust induction of p16 ink4a in response to oncogenic stress, even in cells such as BJ that do not respond by p16 ink4a induction when undergoing senescence triggered by non-oncogenic stimuli. The overall picture emerging is that p16 ink4a , albeit not essential for every mode of cellular senescence, is critical for the formation of SAHF, 4 robust engagement of pRb and irreversible cell cycle arrest, 62, 63 attributes ©2 0 1 1 L a n d e s B i o s c i e n c e .
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cells to dead cells; i.e., 70% activity for BJ, MRC5 and HEKn. Medium was routinely changed 72 hours after a single HdCDTadministration. Cells were routinely harvested at day 12 or as specified. Indirect immunofluorescence. For immunofluorescence microscopy, cells cultured on coverslips were fixed in 4% formaldehyde and permeabilized by 0.1% Triton X-100 in two consecutive steps, each for 15 minutes at RT, essentially as described in reference 76 and 77. After washing with PBS, cells were blocked for 30 minutes in 10% foetal calf serum. The following primary antibodies were used: mouse monoclonal antibody against histone H2A.X phosphorylated at serine 139 (γH2AX; Abcam, # ab22551, 1:500), rabbit polyclonal antibody against histone H3 trimethylated at lysine 9 (H3K9Me3, Milipore, # 07-442, 1:1,000) and mouse monoclonal antibody against heterochromatin protein-1γ (HP1γ, Chemicon, # MAB3450, 1:4,000). Incubation with primary antibodies was performed for 60 minutes at RT and then cells were washed with PBS. Secondary antibodies Alexa Fluor ® 488 goat anti-rabbit (Invitrogen, #A11034, 1:500) and Alexa Fluor ® 568 goat anti-mouse (Invitrogen, #A110-31, 1:500) were then applied for 60 minutes at RT, followed by final wash in PBS. Coverslips were mounted in Vectashield Mounting Medium with DAPI (Vector Laboratories, # H-1200). Confocal images were acquired on LSM-510 (Carl Zeiss Microimaging Inc., Germany) equipped with Plan-Apochromat 63x/1.4 oil immersion objective, ZEN2009 software (Carl Zeiss Microimaging Inc., Germany) and with appropriate configurations for multiple color acquisition. For quantitative and comparative imaging, identical image acquisition parameters were used.
BrdU proliferation assay. Cells cultured on coverslips were incubated with 10 μM BrdU (Sigma, B5002) for 6 hours before fixation with 4% formaldehyde. After DNA denaturation in 2 M HCl for 30 minutes, cells were washed in PBS and incubated with mouse monoclonal antibody against BrdU (APbiotech, RPN20AB, 1:1,300) and stained as described above. Images were acquired on a widefield fluorescence microscope AxioObserver (Carl Zeiss Microimaging Inc., Germany) equipped with Plan Apochromat 20x/0.8 objective, camera Coolsnap HQ (Roper Scientific, Germany) and Metamorph software (Universal Imaging Corporation Ltd., Great Britain).
Senescence associated-β-galactosidase assay. Staining for SA-β-gal activity was performed at day 12 using Senescence β-Galactosidase Staining Kit (Cell Signaling Technology, # 9860) following manufacturer's protocol. Images were captured by fluorescence microscope Zeiss Axioplan 2 (Carl Zeiss Microimaging Inc., Germany) equipped with Plan Neofluar 20x/0.5 objective, color camera Infinity X and Deltapix software (both Deltapix, Denmark).
SDS-PAGE and western blotting. Cells were harvested into Laemmli SDS sample lysis buffer (50 mM Tris pH 6.8; 100 mM DTT; 2% SDS; 0.1% bromphenol blue; 10% glycerol) supplemented with a cocktail of protease inhibitors Complete Mini, EDTA-free (Roche Diagnostics, # 04693159001) and a cocktail of phosphatase inhibitors PhosSTOP (Roche Diagnostics, # 04906845001), sonicated and centrifuged at 16,000x g for 10 minutes. Protein concentration was estimated by the BCA The understanding of heterochromatin biology including SAHF formation has advanced rapidly in recent years; however, it is also evident that many outstanding questions remain to be answered. Relevant to our present study, examples of such questions may include: (1) the potential existence of distinct SAHF structures, only one of which displays the typical DNA/DAPIdefined foci, and their impact on gene expression; (2) what is the contribution, if any, of oxidative stress in general, and high oxygen tension or other artificial conditions to SAHF formation, activation of the p16 ink4a -pRb pathway and cellular immortalization versus senescence; (3) potential distinct biological functions of heterochromatin, including effects on DDR, under various pathological conditions such as aging or cancer progression. On a positive note, one potential avenue to personalized treatment, based on genetic profiles, DDR and heterochromatin states, could be to modulate chromatin modifications such as methylation or acetylation, to synergize with endogenous DNA damage signaling that occurs in most tumors, 72 and/or with standard-of-care genotoxic therapies, to selectively sensitize and eliminate tumor cells.
Materials and Methods
Chemicals. Hydroxyurea (Sigma, # H8627) and doxorubicin (Sigma, # D1515) were dissolved in H 2 O. Etoposide (Sigma, # E1383) was diluted in DMSO. Recombinant toxin from H. ducreyi was prepared by Dr. Frisan (Karolinska Institutet, Stockholm, Sweden). Preparation of CdtA, CdtB and CdtC subunits and reconstitution of the active holotoxin (HdCDT) was previously described in references 47 and 75.
Cell cultures. Normal human fibroblasts BJ and MRC-5 (both from ATCC and at population doublings between 27 and 37) were cultured in Dulbecco's modified Eagle's medium (D-MEM, Invitrogen, # 31966) supplemented with 10% foetal bovine serum (FBS, Invitrogen, # 10270-106) and penicillin/ streptomycin (Invitrogen, # 15140122). Cells were kept at 37°C under 5% CO 2 atmosphere and 95% humidity. Neonatal Human Epidermal Keratinocytes (HEKn; Invitrogen, # C-001-5C) were cultured in EpiLife Medium (Invitrogen, # M-EPI-500-CA) supplemented with HKGS Kit (Invitrogen, # S-001-K) at population doublings between four and ten. HEKn were kept in a humidified atmosphere of 5% CO 2 and 3% O 2 at 37°C. To reach replicative senescence, MRC-5 cells were passaged until population doubling 48, while BJ cells required longer cultivation, until population doubling 86 under similar culture conditions. Induction of premature cellular senescence in vitro. In pilot experiments, cells were treated with various concentrations of individual drugs to select best concentration leading to senescence. 600 μM hydroxyurea, 10 μM etoposide and 100 ng/ml doxorubicin were chosen as the most suitable for routine administration to reach senescence in the majority of cells within the given cell population. Culture medium with fresh additives was changed every 72 h. The 100% activity of bacterial toxin from H. ducreyi was estimated as the lowest cytopathic dose that caused complete irreversible G 2 /M block of 'reference' HeLa cell strain 24 hours after intoxication. 42 For induction of senescence we used 'balanced' toxin dilutions to get optimal ratio of surviving ©2 0 1 1 L a n d e s B i o s c i e n c e .
D o n o t d i s t r i b u t e .
formaldehyde-fixed, de-paraffinized tissue sections were stained overnight with rabbit polyclonal antibody against histone H3 trimethylated at lysine 9 (H3K9Me3, Milipore, # 07-442, 1:1,000) and for one hour with secondary antibody Alexa Fluor ® 488 goat anti-rabbit (Invitrogen, #A11034, 1:500). Samples were mounted into Vectashield Mounting Medium with DAPI (Vector Laboratories, # H-1200). Data on expression of SA-β-gal on frozen sections, and γH2AX, HP1γ and p16 ink4a on the paraffin sections were available from our previous study using immunoperoxidase-based analysis. 48 The newly obtained immunofluorescence images for DAPI and H3K9Me3 were acquired as described above, and examples of the results are presented in Framework Programme (Projects Infla-Care and TRIREME).
Note
Supplemental materials can be found at: www.landesbioscience.com/journals/cc/article/14707 method (Pierce Biotechnology Inc., # 23225). 0.01% bromphenol and 100 mM DTT were added to lysates before separation in 15% polyacrylamide gels by SDS-PAGE (20 μg of protein was loaded per lane). Proteins were electrotransferred onto nitrocellulose membrane (LI-COR, 926-31092) using semidry transfer followed by staining with Ponceau S to verify transfer and equal loading. Staining with mouse monoclonal antibody against p16 ink4a (Sigma, # P0968, 1:130) and mouse antibody against alpha-tubulin (Sigma, T6199, 1:10,000) was performed overnight. Detection was performed by goat anti-mouse IRDye 800CW antibody (LI-COR, # 926-32210) using Odyssey Imaging System equipped with Odyssey software (LI-COR, Nebraska, USA). Alpha-tubulin was used as a marker to ensure equal loading.
Vectors and viral infections. The following lentiviral vectors were used: expression vector pCDH-CMV-MCS-EF1-Puro (System Biosciences, # CD510B-1) empty or with H-Ras V12 insert, packaging vectors pMD2G (Addgene, # 12259) and psPAX2 (Addgene, # 12260). Lentiviral gene transfer was performed as described in reference 78. The infected population was selected using 2 μg/ml puromycin (Sigma, # P7255) for 72 hours.
Human tissue specimens and immunohistochemistry. The paraffin blocks of archival tissue specimens of normal human colon, urinary bladder, skin and series of colon adenomas (n = 38) and carcinomas (n = 44), and urinary bladder tumors (n = 19, including nine cases of Ta lesions and ten cases of T1 lesions) were described previously in reference 48. Samples of frozen tissues of human adenomas (n = 14) were stored at -80°C. All samples were originally collected at the University hospitals in Aarhus and Copenhagen, under ethical approval received from a local Medical Research Ethics Committee in Denmark. The diagnoses were independently verified by two experienced pathologists according to the established criteria of classification recommended by the World Health Organization. The samples of the majority of the tissues (except the 14 cryopreserved adenoma specimens) were fixed in buffered formalin, embedded in paraffin wax and the tissue sections examined by routine histopathology methods and by immunohistochemistry, as reported previously in reference 48 and 53. For immunohistochemistry,
